NMRA
Neumora Therapeutics, Inc.
0.5253$
+5.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.0% | -4.8% | +1.3% | -2.5% | +0.6% | +0.0% | -87.9% | +21.1% | -60.9% | -11.1% | -12.5% | – | |
| – | -6.2% | +21.8% | +73.2% | -22.1% | -0.4% | -5.8% | -23.2% | -16.5% | +23.9% | 0.0% | -3.0% | – | |
| – | – | – | -351.5% | – | -104.6% | – | – | – | -28.4% | -123.8% | – | – | |
| – | +18.9% | +1,661.4% | -100.0% | – | -100.0% | – | – | – | +0.0% | -100.0% | – | – | |
| – | -42.6% | -1,196.7% | – | +638.6% | -162.9% | – | -31.2% | +68.8% | -16.9% | -99.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.2% | – | +43.8% | -42.3% | +917.2% | -100.0% | – | -100.7% | – | -81.5% | -14.6% | – | |
| – | -118.4% | – | – | – | -206.8% | – | – | – | +1,075.4% | -166.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.